Table 2.
Proportions of donors with study outcomes at last follow-up
| Outcome (Events/donors With Data) | BMI Category | ||
|---|---|---|---|
| <30 kg/m2 | 30–34.9 kg/m2 | ≥35 kg/m2 | |
| n (%) | n (%) | n (%) | |
| Death (n=418/n=8583) | 363 (5.3) | 43 (3.2) | 12 (2.8) |
| CVD (n=1085/n=8569) | 865 (12.7) | 162 (12.2) | 58 (13.7) |
| Diabetes (n=566/n=7879) | 424 (6.8) | 98 (8.0) | 44 (11.1) |
| Hypertension (n=2298/n=7696) | 1773 (28.5) | 396 (35.4) | 129 (37.4) |
| Proteinuria (n=1073/n=7687) | 790 (13.0) | 201 (16.6) | 82 (21.4) |
| eGFR <60 (n=4655/n=8374) | 3598 (54.0) | 824 (63.1) | 233 (56.8) |
| eGFR <45 (n=1011/n=8374) | 750 (11.3) | 207 (15.9) | 54 (13.2) |
| eGFR <30 (n=59/n=8374) | 42 (0.6) | 13 (1.0) | 4 (1.0) |
| ESKD (n=43/n=8016) | 31 (0.5) | 8 (0.6) | 4 (1.0) |
| eGFR<30 or ESKD (n=85/n=8552) | 60 (0.9) | 18 (1.4) | 7 (1.7) |
n, number of outcome events; N, total number of donors with ascertained outcome status. This table presents all donors who had outcomes at study end in 2010–2012 (prevalent patients, i.e., also includes donors with a pre-existing condition).